Articles

Search all Cancer Immunology, Immunotherapy articles

Filter by

Volume:

Sort by

Date published:

New to old Old to new

Showing 1-50 of 6,771 articles

PD-1 blockade does not improve efficacy of EpCAM-directed CAR T-cell in lung cancer brain metastasis
Jens Blobner
Laura Dengler
Louisa von Baumgarten
Research Open access 03 October 2024 Article: 255
PD-L1⁺ neutrophils induced NETs in malignant ascites is a potential biomarker in HCC
Xiaoyu Sun
Yaoqi Gui
Bo Wang
Research Open access 03 October 2024 Article: 254
GPCRs: emerging targets for novel T cell immune checkpoint therapy
Kaitlyn Dickinson
Elliott J. Yee
Yuwen Zhu
Review Open access 03 October 2024 Article: 253
Immunotherapy may be more appropriate for ERBB2 low-expressing extramammary paget’s disease patients: a prognosis analysis and exploration of targeted therapy and immunotherapy of extramammary paget’s disease patients
Jiawen Yang
Yurong Chen
Ying Yuan
Research Open access 03 October 2024 Article: 252
Exploring the impact of durvalumab on biliary tract cancer: insights from real-world clinical data
Patrick Reimann
Ilektra-Antonia Mavroeidi
Bernhard Doleschal
Research Open access 03 October 2024 Article: 251
Multi-omics analysis and response prediction of PD-1 monoclonal antibody containing regimens in patients with relapsed/refractory diffuse large B-cell lymphoma
Xinrui Chen
Yan Qin
Yuankai Shi
Research Open access 03 October 2024 Article: 250
Effectiveness, safety, and biomarker analysis of lenvatinib plus toripalimab as chemo-free therapy in advanced intrahepatic cholangiocarcinoma: a real-world study
Shanshan Wang
Jiashuo Chao
Haitao Zhao
Research Open access 03 October 2024 Article: 249
Enhanced anti-tumor efficacy of electroporation (EP)-mediated DNA vaccine boosted by allogeneic lymphocytes in pre-established tumor models
Sanyuan Shi
Luchen Zhang
Yuhong Xu
Research Open access 03 October 2024 Article: 248
HLA-G neo-expression modifies genetic programs governing tumor cell lines
Diana Tronik-Le Roux
Marina Daouya
Edgardo D. Carosella
Research Open access 03 October 2024 Article: 247
Development and validation of a new tool to estimate early mortality in patients with advanced cancer treated with immunotherapy
Andrea De Giglio
Alessandro Leonetti
Andrea Ardizzoni
Research Open access 03 October 2024 Article: 246
NitraTh epitope-based neoantigen vaccines for effective tumor immunotherapy
Wanli Zhang
Xupeiyao Shi
Wenbing Yao
Research Open access 03 October 2024 Article: 245
Toripalimab combined with definitive chemoradiotherapy for locally advanced cervical squamous cell carcinoma patients (TRACE): A single-arm, phase I/II trial
Dan Ou
Rong Cai
Hao-Ping Xu
Research Open access 03 October 2024 Article: 244
Dose-escalation, tolerability, and efficacy of intratumoral and subcutaneous injection of hemagglutinating virus of Japan envelope (HVJ-E) against chemotherapy-resistant malignant pleural mesothelioma: a clinical trial
Kazuma Sakura
Muneyoshi Kuroyama
Yasufumi Kaneda
Research Open access 03 October 2024 Article: 243
Therapeutic antibodies in oncology: an immunopharmacological overview
Karen Toledo-Stuardo
Carolina H. Ribeiro
María Carmen Molina
Review Open access 03 October 2024 Article: 242
A random survival forest-based pathomics signature classifies immunotherapy prognosis and profiles TIME and genomics in ES-SCLC patients
Yuxin Jiang
Yueying Chen
Ping Zhan
Research Open access 03 October 2024 Article: 241
Efficacy and safety of lenvatinib combined with anti-PD-1 antibodies plus GEMOX chemotherapy as non-first-line systemic therapy in advanced gallbladder cancer
Yang Tan
Kai Liu
Haitao Zhao
Research Open access 03 October 2024 Article: 240
INTASYL self-delivering RNAi decreases TIGIT expression, enhancing NK cell cytotoxicity: a potential application to increase the efficacy of NK adoptive cell therapy against cancer
Melissa Maxwell
Dingxue Yan
Elfriede Noessner
Research Open access 03 October 2024 Article: 239
Part of 1 collection:

Natural Killer cell therapy
The relevance of tumor target expression levels on IgA-mediated cytotoxicity in cancer immunotherapy
Chilam Chan
Núria Casalé Cabanes
Jeanette H. W. Leusen
Research Open access 03 October 2024 Article: 238
Tumor immunogenicity regulates host immune responses, and conventional dendritic cell type 2 uptakes the majority of tumor antigens in an orthotopic lung cancer model
Ki-Hyun Kim
Seung-jae Kim
Gye Young Park
Brief Report Open access 03 October 2024 Article: 237
Correction to: Inhibition of glycolysis enhances the efficacy of immunotherapy via PDK‑mediated upregulation of PD‑L1
Ruizhi Zhang
Gan Mao
Wei Li
Correction Open access 17 September 2024 Article: 236
Bronchoalveolar lavage fluid analysis in patients with checkpoint inhibitor pneumonitis
Ruxuan Chen
Yujie Shi
Mengzhao Wang
Research Open access 13 September 2024 Article: 235
Genomic and molecular alterations associated with primary resistance to immune checkpoint inhibitors
Jyoti Malhotra
Subhajyoti De
Victoria Villaflor
Review Open access 13 September 2024 Article: 234
Single-cell RNA sequencing to map tumor heterogeneity in gastric carcinogenesis paving roads to individualized therapy
Jiao Xu
Bixin Yu
Jin Yang
Review Open access 13 September 2024 Article: 233
Recent clinical researches and technological development in TIL therapy
Satoko Matsueda
Lei Chen
Fuli Yu
Review Open access 12 September 2024 Article: 232
A monoclonal antibody recognizing CD98 on human embryonic stem cells shows anti-tumor activity in hepatocellular carcinoma xenografts
Keunpyo Lim
San Ha Han
Chun Jeih Ryu
Research Open access 11 September 2024 Article: 231
Adjuvant chemoradiotherapy plus pembrolizumab for locally advanced esophageal squamous cell carcinoma with high risk of recurrence following neoadjuvant chemoradiotherapy: a single-arm phase II study
Jhe-Cyuan Guo
Ta-Chen Huang
Chih-Hung Hsu
Research Open access 09 September 2024 Article: 230
Secretome and immune cell attraction analysis of head and neck cancers
Tara Muijlwijk
Niels E. Wondergem
Rieneke van de Ven
Research Open access 09 September 2024 Article: 229
Disruptions in antigen processing and presentation machinery on sarcoma
Salvatore Lorenzo Renne
Laura Sama’
Ferdinando Carlo Maria Cananzi
Research Open access 09 September 2024 Article: 228
Adding-on nivolumab to chemotherapy-stabilized patients is associated with improved survival in advanced pancreatic ductal adenocarcinoma
Shih-Hung Yang
Sung-Hsin Kuo
Kun-Huei Yeh
Research Open access 09 September 2024 Article: 227
Triple therapy boosts survival in NSCLC patients with brain metastases: a retrospective cohort study of chemotherapy, ICIs, and antiangiogenic agents
Dingyi Yang
Erha Munai
Xiao-Dong Zhu
Research Open access 06 September 2024 Article: 226
Impaired TGF-β signaling via AHNAK family mutations elicits an esophageal cancer subtype with sensitivities to genotoxic therapy and immunotherapy
Zihang Mai
Kongjia Luo
Jianhua Fu
Research Open access 05 September 2024 Article: 225
Correction to: Impact of fludarabine and treosulfan on ovarian tumor cells and mesothelin chimeric antigen receptor T cells
Ibrahim El-Seraf
Isabella Micallef Nilsson
Isabelle Magalhaes
Correction Open access 05 September 2024 Article: 224
Distribution characteristics of immune infiltration and lymphovascular invasion in patients with breast cancer skin recurrence
Danyang Zhou
Mei Li
Ruoxi Hong
Research Open access 05 September 2024 Article: 223
A comprehensive and longitudinal evaluation of the different populations of lymphoid and myeloid cells in the peripheral blood of patients treated with chemoradiotherapy for head and neck cancer
Jens von der Grün
Martina Broglie
Panagiotis Balermpas
Research Open access 05 September 2024 Article: 222
Oncolytic virotherapy augments self-maintaining natural killer cell line cytotoxicity against neuroblastoma
Colin H. Quinn
Janet R. Julson
Elizabeth A. Beierle
Research Open access 05 September 2024 Article: 221
Efficacy of durvalumab plus chemotherapy in advanced biliary duct cancer and biomarkers exploration
Yunxin Lu
Yin Jin
Dongsheng Zhang
Research Open access 05 September 2024 Article: 220
SAFFRON-104: a phase Ib/II study of sitravatinib alone or with tislelizumab in advanced hepatocellular carcinoma and gastric cancer/gastroesophageal junction cancer
Jin Li
Yuxian Bai
Shukui Qin
Research Open access 05 September 2024 Article: 219
Stat3-mediated Atg7 expression regulates anti-tumor immunity in mouse melanoma
Sarah M. Zimmerman
Erin Suh
George P. Souroullas
Brief Report Open access 05 September 2024 Article: 218
Immunogenomic features of radiologically distinctive nodules in multiple primary lung cancer
Mei-Cheng Chen
Hao-Shuai Yang
Ying Zhu
Research Open access 05 September 2024 Article: 217
The short-term efficacy of neoadjuvant SOX versus SOX plus immune checkpoint inhibitor following laparoscopic gastrectomy for locally advanced gastric cancer: a multicenter retrospective cohort study in China
Hao Cui
Yongpu Yang
Bo Wei
Research Open access 05 September 2024 Article: 216
Immune microenvironmental heterogeneity according to tumor DNA methylation phenotypes in microsatellite instability-high colorectal cancers
Jung Ho Kim
Jiyun Hong
Sangwoo Kim
Research Open access 05 September 2024 Article: 215
Characterization of pre- and on-treatment soluble immune mediators and the tumor microenvironment in NSCLC patients receiving PD-1/L1 inhibitor monotherapy
Daiki Murata
Koichi Azuma
Tomoaki Hoshino
Research Open access 05 September 2024 Article: 214
High proportion of PD-1 and CD39 positive CD8+ tissue resident T lymphocytes correlates with better clinical outcome in resected human oesophageal adenocarcinoma
Samuel L. Hill
Gessa Sugiyarto
Tim Elliott
Brief Report Open access 05 September 2024 Article: 213
Increasing monocytes after lung cancer surgery triggers the outgrowth of distant metastases, causing recurrence
Yo Kawaguchi
Keigo Okamoto
Jun Hanaoka
Research Open access 05 September 2024 Article: 212
Outcome of immune checkpoint inhibitor treatment in non-small cell lung cancer patients with interstitial lung abnormalities: clinical utility of subcategorizing interstitial lung abnormalities
Ryota Kikuchi
Yusuke Watanabe
Shinji Abe
Research Open access 05 September 2024 Article: 211
Part of 1 collection:

Adverse Drug Reactions in Immunotherapy: Safety and Management
Preclinical development of a novel CCR8/CTLA-4 bispecific antibody for cancer treatment by disrupting CTLA-4 signaling on CD8 T cells and specifically depleting tumor-resident Tregs
Cuicui Guo
Xiaodong Dai
Xun Gui
Research Open access 09 August 2024 Article: 210
NKG2D-bispecific enhances NK and CD8+ T cell antitumor immunity
Aurelie Herault
Judy Mak
Kevin B. Walsh
Research Open access 08 August 2024 Article: 209
DNA hypo-methylation and expression of GBP4 induces T cell exhaustion in pancreatic cancer
Yesiboli Tasiheng
Xuan Lin
Chen Liu
Research Open access 07 August 2024 Article: 208
Unlocking the potential of HHLA2: identifying functional immune infiltrating cells in the tumor microenvironment and predicting clinical outcomes in laryngeal squamous cell carcinoma
Wenjing Li
Jianqing You
Changping Wu
Research Open access 06 August 2024 Article: 207
Deciphering the interplay of HPV infection, MHC-II expression, and CXCL13⁺ CD4⁺ T cell activation in oropharyngeal cancer: implications for immunotherapy
Shida Yan
Xing Zhang
Ming Song
Research Open access 06 August 2024 Article: 206

1
2
…
136
Next page